SFX by Ex Libris Inc.

Title:	Rapamycin-Induced Inhibition of the 70-Kilodalton S6 Protein Kinase
Source:	Science [0036-8075] Price, Daniel yr:1992

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	"Formulation of cost-effective medium and optimization studies for enhanced production of rapamycin." Microbial cell factories. 22.1: 189-.
description	2.	Choi, J. "AKT is involved in granulosa cell autophagy regulation via mTOR signaling during rat follicular development and atresia." Reproduction 147.1 (2013): 73-80.
description	3.	"PHARMACEUTICAL TIMES: New product launches. [4 figures]." Chemical Business Newsbase (2001): 1-.
description	4.	Kuo, Calvin J. "Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase." Nature 358.6381 (1992): 70-73.
description	5.	Bierer, B E E. "Cyclosporin A and FK506: molecular mechanisms of immunosuppression and probes for transplantation biology." Current opinion in immunology 5.5 (1993): 763-73.
description	6.	Chung, J. "Kuo, CJ, Crabtree, GR, and Blenis, J.(1992)." Cell (Cell Press) 69: 9231-.
description	7.	Hurel, S J. "Insulin action in cultured human myoblasts: contribution of different signalling pathways to regulation of glycogen synthesis." Biochemical journal 320 ( Pt 3) (1996): 871-7.
description	8.	Calvo, V. "Activation of 70-kDa S6 kinase, induced by the cytokines interleukin-3 and erythropoietin and inhibited by rapamycin, is not an absolute requirement for cell proliferation." European journal of immunology 24.11 (1994): 2664-71.
description	9.	McNatty, K. "The conflict between hierarchical ovarian follicular development and superovulation treatment." Reproduction 140.2 (2010): 287-294.
description	10.	Sengupta, S. "Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress." Molecular cell 40.2 (2010): 310-322.
description	11.	Holländer, G A A. "Molecular and biological actions of cyclosporin A and FK506 on T cell development and function." Transfusion science 15.3 (1994): 207-20.
description	12.	Schuurman, Henk-Jan G. "Histopathology of the immune system as a tool to assess immunotoxicity." Toxicology 86.3 (1994): 187-212.
description	13.	Su, B. "JNK is involved in signal integration during costimulation of T lymphocytes." Cell 77.5 (1994): 727-36.
description	14.	Chang, J Y Y. "Pharmacology of rapamycin: a new immunosuppressive agent." British journal of rheumatology 30 Suppl 2 (1991): 62-5.
description	15.	Konz, D. "How do peptide synthetases generate structural diversity?" Chemistry & biology 6.2 (1999): 39-48.
description	16.	Brown, Eric J. "A mammalian protein targeted by G1-arresting rapamycin-receptor complex." Nature 369.6483 (1994): 756-758.
description	17.	Gothard, John W W W. "Anesthetic considerations for patients with anterior mediastinal masses." Anesthesiology Clinics 26.2 (2008): 305-14.
description	18.	Sabatini, D M M. "RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs." Cell 78.1 (1994): 35-43.
description	19.	Rodgers, Robin y. "Anesthetic management for pediatric strabismus surgery: Continuing professional development." Canadian journal of anesthesia 57.6 (2010): 602-617.
description	20.	Foster, Kathryn G. "Mammalian Target of Rapamycin (mTOR): Conducting the Cellular Signaling Symphony." The Journal of biological chemistry 285.19 (2010): 14071-14077.